Literature DB >> 22435242

False positive rate of serum markers for Down syndrome screening: does transportation have any effect?

Supatra Sirichotiyakul1, Suchaya Luewan, Rattanaporn Sekararith, Theera Tongsong.   

Abstract

OBJECTIVE: To determine the false positive rate of serum markers for Down syndrome screening caused by transportation by analyzing samples sent from different hospitals at various distances. MATERIAL AND
METHOD: The database of serum markers between March 2008 and August 2010 was retrieved from Maternal-Fetal the Medicine unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University. The tests were performed using Delfia Xpress system. The cut off value for positive test result was 1 in 250. RESULT: Two thousand six hundred thirty one samples from hospitals located at various distances ranging from 0 to 449 km were assessed. The overall positive results were 6.1%, ranging from 5.6% among the hospitals near the laboratory to 15.4% among the hospitals far away from the laboratory (p-value < 0.001). The samples from the remote hospitals had significantly higher levels of free beta hCG than those from nearby hospitals (p-value = 0.003).
CONCLUSION: The samples transported from the hospitals far from the laboratory need better storage and shipping procedure to avoid high false positive rate, which leads to unnecessary invasive prenatal diagnosis procedure.

Mesh:

Substances:

Year:  2012        PMID: 22435242

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.

Authors:  Savitree Pranpanus; Ounjai Kor-Anantakul; Thitima Suntharasaj; Chitkasaem Suwanrath; Tharangrut Hanprasertpong; Ninlapa Pruksanusak; Chusana Petpichetchian; Manaphat Suksai; Natthicha Chainarong; Rapphon Sawaddisan
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

2.  Significance of data analysis in the quality control of prenatal screening for Down syndrome.

Authors:  Yahong Li; Xiaojuan Zhang; Dongyang Hong; Xianwei Guan; Shaolei Lv; Yun Sun; Tao Jiang
Journal:  Biomed Rep       Date:  2018-03-15

3.  Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

Authors:  Chanane Wanapirak; Wirawit Piyamongkol; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Kuntharee Traisrisilp; Phudit Jatavan; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.